Hemosense Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/07 Q3

ended 03/31/07 Q2

ended 12/31/06 Q1

ended 09/30/06 FY 2006

ended 06/30/06 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Details of business combination or exchange offer – amended

Details of business combination or exchange offer

Exempt offering of securities

Prospectus supplement

Ownership Filter

Gadicke Ansbert, Evnin Luke, Steinmetz Michael, Galakatos Nicholas, Mpm Asset Management Investors 2000b LLC, Mpm Asset Management II LP, Mpm Asset Management II LLC, Mpm Bioventures II LP, Mpm Bioventures II Qp LP, Mpm Bioventures Gmbh & Co Parallel Beteiligungs Kg

Brennan Edward F

Still Timothy I

News Filter

Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes Due 2016

Receives Patent Infringement Notification From Beckman Coulter

Change in Directors, Officers or Compensation

Fiscal Third Quarter Revenue Increases 101%

Inverness Medical Innovations to Acquire Hemosense, Inc

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Letter from the SEC

Notice of effectiveness

Statement of eligibility as a trustee – amended

Statement of eligibility as a trustee